comparemela.com

Latest Breaking News On - Ameritas investment partners inc - Page 1 : comparemela.com

Short Interest in Enbridge Inc. (NYSE:ENB) Decreases By 72.1%

Enbridge Inc. (NYSE:ENB – Get Free Report) (TSE:ENB) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 22,640,000 shares, a drop of 72.1% from the May 15th total of 81,150,000 shares. Approximately 1.1% of the company’s stock are sold short. Based on an […]

United-states
Canada
Jefferies-financial-group
Ameritas-investment-partners-inc
Baystate-wealth-management
Energy-services
Financial-gravity-asset-management-inc
Enbridge-inc
Financial-private-wealth-inc
Enbridge
Get-free-report

John Zupo Sells 5,017 Shares of The Vita Coco Company, Inc. (NASDAQ:COCO) Stock

The Vita Coco Company, Inc. (NASDAQ:COCO – Get Free Report) Director John Zupo sold 5,017 shares of Vita Coco stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $27.62, for a total transaction of $138,569.54. Following the sale, the director now directly owns 8,247 shares […]

United-states
Canada
New-york
Piper-sandler
Asia-pacific
John-zupo
Vita-coco
Financial-services-group-inc
Nasdaq
Vita-coco-company-inc
Ameritas-investment-partners-inc
Vita-coco-company-profile

Dyne Therapeutics, Inc. (NASDAQ:DYN) COO Sells $2,419,200.00 in Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) COO Susanna Gatti High sold 80,000 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $30.24, for a total value of $2,419,200.00. Following the completion of the transaction, the chief operating officer now owns 154,062 […]

United-states
Piper-sandler
Stifel-nicolaus
Dyne-therapeutics-inc
Nasdaq
Russell-investments-group-ltd
Principal-financial-group-inc
Wetzel-investment-advisors-inc
Ameritas-investment-partners-inc
Mirae-asset-global-investments-co
Securities-exchange-commission
Dyne-therapeutics

Insider Selling: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Insider Sells 35,000 Shares of Stock

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $12.03, for a total transaction of $421,050.00. Following the completion of the sale, the insider now directly owns 197,681 […]

United-states
China
Y-mabs-therapeutics-company-profile
Ameritas-investment-partners-inc
Sg-americas-securities
Securities-exchange-commission
Bailard-inc
Nasdaq
Tower-research-capital
Y-mabs-therapeutics-inc
China-universal-asset-management-co

Annexon (NASDAQ:ANNX) Trading Up 11.9%

Annexon, Inc. (NASDAQ:ANNX – Get Free Report)’s stock price was up 11.9% during trading on Wednesday . The company traded as high as $6.11 and last traded at $6.11. Approximately 587,505 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 2,187,764 shares. The stock had previously closed at […]

United-states
America
Annexon-company-profile
Ameritas-investment-partners-inc
Needham-company
Cantor-fitzgerald
Entrypoint-capital
Tower-research-capital
Nasdaq
Annexon-inc
Jpmorgan-chase-co

vimarsana © 2020. All Rights Reserved.